Benjamin L. Palleiko is CEO at KalVista Pharmaceuticals, Inc. (KALV). They have made 38 open-market trades across 2 companies since 2007, most recently 2026-05-22.
CIK 0001366244
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $16K since 2007, against 37 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| KALV | 479,989 | $13.0M |
| PPCO | 2,500 | — |
| Total | $13.0M |
Shares reported on the most recent Form 4, priced at the 2026-05-26 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KALV | SELL | 2026-05-22 | 2026-05-26 | $26.78 | $293K | +0.7% | N/A | N/A |
| KALV | SELL | 2026-05-18 | 2026-05-19 | $26.76 | $30K | +0.7% | N/A | N/A |
| KALV | SELL | 2026-05-12 | 2026-05-13 | $26.71 | $89K | +0.0% | N/A | N/A |
| KALV | SELL | 2026-04-17 | 2026-04-20 | $20.22 | $193K | +26.2% | +27.0% | N/A |
| KALV | SELL | 2026-03-09 | 2026-03-10 | $16.08 | $108K | -7.4% | +8.7% | +47.0% |
| KALV | SELL | 2026-02-23 | 2026-02-24 | $15.57 | $156K | +2.8% | +20.0% | +69.8% |
| KALV | SELL | 2026-02-18 | 2026-02-19 | $15.00 | $16K | +0.0% | +6.3% | +71.7% |
| KALV | SELL | 2026-02-12 | 2026-02-13 | $15.70 | $53K | +6.3% | +13.5% | +80.6% |
| KALV | SELL | 2025-12-08 | 2025-12-09 | $16.51 | $241K | -5.9% | -2.2% | +6.9% |
| KALV | SELL | 2025-11-24 | 2025-11-26 | $13.45 | $147K | +14.5% | +7.5% | +11.8% |
| KALV | SELL | 2025-11-18 | 2025-11-19 | $14.48 | $129K | -2.2% | +10.1% | +8.4% |
| KALV | SELL | 2025-11-12 | 2025-11-13 | $11.55 | $38K | +1.1% | +28.7% | +18.1% |
| KALV | SELL | 2025-09-08 | 2025-09-09 | $15.84 | $231K | -15.6% | -24.3% | +8.0% |
| KALV | SELL | 2025-08-22 | 2025-08-25 | $13.22 | $289K | +22.8% | +0.2% | +3.6% |
| KALV | SELL | 2025-08-18 | 2025-08-19 | $13.19 | $116K | +5.1% | +8.4% | +16.0% |
| KALV | SELL | 2025-07-09 | 2025-07-10 | $15.69 | $1.0M | +6.3% | -15.9% | -22.8% |
| KALV | SELL | 2025-06-09 | 2025-06-10 | $14.50 | $208K | -17.8% | +6.9% | +10.0% |
| KALV | SELL | 2025-05-22 | 2025-05-23 | $11.88 | $238K | +19.0% | +2.8% | +11.7% |
| KALV | SELL | 2025-05-19 | 2025-05-20 | $11.84 | $45K | +7.0% | +0.7% | +10.5% |
| KALV | SELL | 2025-03-07 | 2025-03-10 | $11.97 | $160K | +0.1% | -9.8% | +23.1% |
| KALV | SELL | 2025-02-18 | 2025-02-19 | $9.82 | $100K | +1.5% | +11.0% | +14.3% |
| KALV | SELL | 2024-12-09 | 2024-12-09 | $9.75 | $149K | -13.6% | -12.0% | +28.1% |
| KALV | SELL | 2024-11-18 | 2024-11-19 | $9.26 | $133K | +14.1% | -10.1% | +8.7% |
| KALV | SELL | 2024-09-09 | 2024-09-10 | $12.19 | $179K | -5.3% | -0.8% | -15.7% |
| KALV | SELL | 2024-08-19 | 2024-08-21 | $12.01 | $341K | -0.9% | -15.9% | -27.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.